• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CASP5 和 CR1 作为川崎病的潜在生物标志物:一项综合生物信息学-实验研究。

CASP5 and CR1 as potential biomarkers for Kawasaki disease: an Integrated Bioinformatics-Experimental Study.

机构信息

Department of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

BMC Pediatr. 2021 Dec 11;21(1):566. doi: 10.1186/s12887-021-03003-5.

DOI:10.1186/s12887-021-03003-5
PMID:34895171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8665509/
Abstract

BACKGROUND

Kawasaki disease (KD) is a pediatric inflammatory disorder causes coronary artery complications. The disease overlapping manifestations with a set of symptomatically like diseases such as bacterial and viral infections, juvenile idiopathic arthritis, Henoch-Schönlein purpura, infection of unknown etiology, group-A streptococcal and adenoviral infections, and incomplete KD could lead to misdiagnosis of the disease.

METHODS

In the present study, we applied weighted gene co-expression network analysis (WGCNA) to identify network modules of co-expressed genes in GSE73464 and also, limma package was used to identify the differentially expressed genes (DEGs) in KD expression arrays composed of GSE73464, GSE18606, GSE109351, and GSE68004. By merging the results of WGCNA and limma, we detected hub genes. Then, analyzed the peripheral blood mononuclear cells (PBMCs) of 16 patients and 8 control subjects using Real-Time Polymerase Chain Reaction (RT-PCR) to evaluate the previous results.

RESULTS

We assessed the diagnostic potency of the screened genes by plotting the area under curve (AUC). We finally identified 2 genes CASP5(Caspase 5) and CR1(Complement C3b/C4b Receptor 1) which were shown to potentially discriminate KD from other similar diseases and also from healthy people.

CONCLUSIONS

The results of RT-PCR and AUC confirmed the diagnostic potentials of two suggested biomarkers for KD.

摘要

背景

川崎病(KD)是一种儿科炎症性疾病,可导致冠状动脉并发症。该疾病与一系列症状相似的疾病重叠,如细菌和病毒感染、幼年特发性关节炎、过敏性紫癜、病因不明的感染、A 组链球菌和腺病毒感染以及不典型 KD,可能导致误诊。

方法

本研究应用加权基因共表达网络分析(WGCNA)鉴定 GSE73464 中基因共表达网络模块,并使用 limma 包鉴定由 GSE73464、GSE18606、GSE109351 和 GSE68004 组成的 KD 表达阵列中的差异表达基因(DEGs)。通过合并 WGCNA 和 limma 的结果,我们检测了枢纽基因。然后,使用实时聚合酶链反应(RT-PCR)分析 16 名患者和 8 名对照者的外周血单核细胞(PBMCs),以评估之前的结果。

结果

我们通过绘制曲线下面积(AUC)来评估筛选基因的诊断效力。我们最终确定了 2 个基因 CASP5(半胱天冬酶 5)和 CR1(补体 C3b/C4b 受体 1),它们可能有助于将 KD 与其他类似疾病以及健康人区分开来。

结论

RT-PCR 和 AUC 的结果证实了这两种 KD 候选生物标志物的诊断潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/013c755dd33a/12887_2021_3003_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/6b65f31a41a8/12887_2021_3003_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/860c49ffd815/12887_2021_3003_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/558a961759fe/12887_2021_3003_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/b57f65c7a047/12887_2021_3003_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/5aad28ad432d/12887_2021_3003_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/5a6843de6e3f/12887_2021_3003_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/013c755dd33a/12887_2021_3003_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/6b65f31a41a8/12887_2021_3003_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/860c49ffd815/12887_2021_3003_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/558a961759fe/12887_2021_3003_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/b57f65c7a047/12887_2021_3003_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/5aad28ad432d/12887_2021_3003_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/5a6843de6e3f/12887_2021_3003_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/8665509/013c755dd33a/12887_2021_3003_Fig7_HTML.jpg

相似文献

1
CASP5 and CR1 as potential biomarkers for Kawasaki disease: an Integrated Bioinformatics-Experimental Study.CASP5 和 CR1 作为川崎病的潜在生物标志物:一项综合生物信息学-实验研究。
BMC Pediatr. 2021 Dec 11;21(1):566. doi: 10.1186/s12887-021-03003-5.
2
Exploring Kawasaki disease-specific hub genes revealing a striking similarity of expression profile to bacterial infections using weighted gene co-expression network analysis (WGCNA) and co-expression modules identification tool (CEMiTool): An integrated bioinformatics and experimental study.运用加权基因共表达网络分析(WGCNA)和共表达模块识别工具(CEMiTool)探索川崎病特异性枢纽基因,揭示其与细菌感染表达谱的惊人相似性:一项综合生物信息学和实验研究。
Immunobiology. 2020 Jul;225(4):151980. doi: 10.1016/j.imbio.2020.151980. Epub 2020 Jul 6.
3
Identification of hub biomarkers and immune-related pathways participating in the progression of Kawasaki disease by integrated bioinformatics analysis.通过综合生物信息学分析鉴定参与川崎病进展的关键生物标志物和免疫相关途径。
Immunobiology. 2023 Nov;228(6):152750. doi: 10.1016/j.imbio.2023.152750. Epub 2023 Sep 26.
4
Comprehensive analyses of DNA methylation and gene expression profiles of Kawasaki disease.川崎病 DNA 甲基化和基因表达谱的综合分析。
J Cell Biochem. 2019 Aug;120(8):13001-13011. doi: 10.1002/jcb.28571. Epub 2019 Mar 12.
5
Bioinformatic analysis of underlying mechanisms of Kawasaki disease via Weighted Gene Correlation Network Analysis (WGCNA) and the Least Absolute Shrinkage and Selection Operator method (LASSO) regression model.通过加权基因共表达网络分析(WGCNA)和最小绝对收缩与选择算子法(LASSO)回归模型对川崎病潜在机制的生物信息学分析
BMC Pediatr. 2023 Feb 24;23(1):90. doi: 10.1186/s12887-023-03896-4.
6
Prediction of Immune Infiltration Diagnostic Gene Biomarkers in Kawasaki Disease.川崎病免疫浸润诊断基因生物标志物的预测。
J Immunol Res. 2022 Jun 17;2022:8739498. doi: 10.1155/2022/8739498. eCollection 2022.
7
Identifying differentially expressed genes and miRNAs in Kawasaki disease by bioinformatics analysis.通过生物信息学分析鉴定川崎病差异表达的基因和 miRNA。
Sci Rep. 2022 Dec 19;12(1):21879. doi: 10.1038/s41598-022-26608-x.
8
Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study.脓毒性休克的 6 个潜在生物标志物:一项深入的生物信息学和前瞻性观察研究。
Front Immunol. 2023 Jun 8;14:1184700. doi: 10.3389/fimmu.2023.1184700. eCollection 2023.
9
Explore the mechanism of incomplete Kawasaki disease and identify a novel biomarker by weighted gene co-expression network analysis.探讨不完全川崎病的发病机制,并通过加权基因共表达网络分析鉴定新的生物标志物。
Immunobiology. 2022 Nov;227(6):152285. doi: 10.1016/j.imbio.2022.152285. Epub 2022 Oct 8.
10
Diagnostic Significance of miR-937 in Peripheral Blood Mononuclear Cells of Kawasaki Disease.miR-937在川崎病外周血单个核细胞中的诊断意义
Clin Lab. 2019 Nov 1;65(11). doi: 10.7754/Clin.Lab.2019.190507.

引用本文的文献

1
Identifying differentially expressed genes and miRNAs in Kawasaki disease by bioinformatics analysis.通过生物信息学分析鉴定川崎病差异表达的基因和 miRNA。
Sci Rep. 2022 Dec 19;12(1):21879. doi: 10.1038/s41598-022-26608-x.
2
Prediction of Immune Infiltration Diagnostic Gene Biomarkers in Kawasaki Disease.川崎病免疫浸润诊断基因生物标志物的预测。
J Immunol Res. 2022 Jun 17;2022:8739498. doi: 10.1155/2022/8739498. eCollection 2022.

本文引用的文献

1
Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead.川崎病的生物标志物:临床应用及面临的挑战
Front Pediatr. 2019 Jun 18;7:242. doi: 10.3389/fped.2019.00242. eCollection 2019.
2
The Epidemiology and Pathogenesis of Kawasaki Disease.川崎病的流行病学与发病机制
Front Pediatr. 2018 Dec 11;6:374. doi: 10.3389/fped.2018.00374. eCollection 2018.
3
Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data.通过转录组数据网络分析鉴定的膀胱癌新生物标志物
Front Oncol. 2018 Oct 12;8:450. doi: 10.3389/fonc.2018.00450. eCollection 2018.
4
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.全基因组多基因疾病风险评分可识别出与单基因突变风险相当的个体。
Nat Genet. 2018 Sep;50(9):1219-1224. doi: 10.1038/s41588-018-0183-z. Epub 2018 Aug 13.
5
Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature.采用最小全血基因表达特征诊断川崎病。
JAMA Pediatr. 2018 Oct 1;172(10):e182293. doi: 10.1001/jamapediatrics.2018.2293.
6
Epidemiological observations of Kawasaki disease in Japan, 2013-2014.2013 - 2014年日本川崎病的流行病学观察
Pediatr Int. 2018 Jun;60(6):581-587. doi: 10.1111/ped.13544.
7
The genetics of Kawasaki disease.川崎病的遗传学
Int J Rheum Dis. 2018 Jan;21(1):26-30. doi: 10.1111/1756-185X.13218. Epub 2017 Nov 19.
8
Diagnosis of Kawasaki disease.川崎病的诊断
Int J Rheum Dis. 2018 Jan;21(1):36-44. doi: 10.1111/1756-185X.13224. Epub 2017 Nov 13.
9
Is Kawasaki disease an infectious disorder?川崎病是一种传染性疾病吗?
Int J Rheum Dis. 2018 Jan;21(1):20-25. doi: 10.1111/1756-185X.13213. Epub 2017 Nov 3.
10
Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children.白细胞介素-21(IL-21)的观察性研究无法区分川崎病与儿童其他发热原因。
Pediatr Rheumatol Online J. 2017 Apr 20;15(1):32. doi: 10.1186/s12969-017-0163-3.